[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339709-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339709-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","phage-display-technology-in-biomarker-identification-with-emphasis-on-non-cancerous-diseases-review","Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases - Review","","Recent years have shown phage display technology becoming essential to clinical research workflows. The method enables the generation of antibodies that bind complex antigens with high specificity, supporting biomarker identification and the development of improved diagnostics and therapies. Many prior reviews concentrate primarily on cancer, leaving non-oncological applications less discussed. This review explains phage display fundamentals and highlights uses in detecting and addressing multiple non-cancerous conditions, including degenerative, inflammatory, autoimmune, and chronic non-communicable diseases.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/phage-display-technology-in-biomarker-identification-with-emphasis-on-non-cancerous-diseases-review/339709/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/phage-display-technology-in-biomarker-identification-with-emphasis-on-non-cancerous-diseases-review/339709.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is phage display technology used for in biomarker research?","Question",{"text":63,"@type":64},"Phage display supports the creation of antibodies that bind specifically to complex antigens, enabling biomarker identification and advancements in diagnostics and treatment strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does phage display contribute to identifying peptides and antigens?",{"text":68,"@type":64},"It addresses challenges in mapping peptides and antigens across different epitope and peptide spectra by providing a versatile framework for selection and binding discovery.",{"name":70,"@type":61,"acceptedAnswer":71},"Why does this review focus on non-cancerous diseases?",{"text":72,"@type":64},"Existing reviews often underrepresent phage display’s importance beyond oncology. The work emphasizes its role across degenerative diseases, inflammatory and autoimmune diseases, and chronic non-communicable diseases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339709,1790240743,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","molecules   \nReview  \nPhage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases  \nMohammad Sadraeian 1, Reza Maleki 2, Mahta Moraghebi 2 and Abasalt Bahrami 3, *,†  \nCitation: Sadraeian, M.; Maleki, R.; Moraghebi, M.; Bahrami, A. Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases. Molecules 2024, 29, 3002. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/molecules29133002](10.3390/molecules29133002)  \nAcademic Editors: Matteo Calvaresi and Hyun-Ock Pae  \nReceived: 12 March 2024  \nRevised: 17 April 2024  \nAccepted: 29 April 2024  \nPublished: 25 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia; [mohammad.sadraeian@uts.edu.au](mohammad.sadraeian@uts.edu.au)  \n2 Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia  \n3 Department of Chemistry and Biochemistry, Bioengineering, and Materials Science and Engineering, University of California, Los Angeles, CA 90095, USA  \n* Correspondence: [abasalt@ucla.edu](abasalt@ucla.edu); Tel.: +1-872-985-8327  \n† Current address: Department of Neurology, Integrative Center for Learning and Memory, Brain Research Institute, University of California, Los Angeles, CA 90095, USA.  \nAbstract: In recent years, phage display technology has become vital in clinical research. It helps create antibodies that can specifically bind to complex antigens, which is crucial for identifying biomarkers and improving diagnostics and treatments. However, existing reviews often overlook its importance in areas outside cancer research. This review aims to fill that gap by explaining the basics of phage display and its applications in detecting and treating various non-cancerous diseases. We focus especially on its role in degenerative diseases, inflammatory and autoimmune diseases, and chronic non-communicable diseases, showing how it is changing the way we diagnose and treat illnesses. By highlighting important discoveries and future possibilities, we hope to emphasize the significance of phage display in modern healthcare.  \nKeywords: phage display; biopanning; diagnosis; therapeutic applications  \n1. Introduction  \nThe concept of phage display was originally proposed by George P. Smith who used filamentous bacteriophages M13 to insert protein-coding genes and called the process of adopting a specific protein “panning” [1] . Phage display is a cost-efficient technique used to identify peptides that serve to enhance antigen–antibody interactions. The integration of gene engineering and combinatorial chemistry has been carried out in the phage display technology that utilizes exogenous DNA to be interested in phage coat encoding sequences as well as filamentous phage genomes [2] . After being expressed, phage particles are generated which carry the coat protein of the phage combined with the sequence of interest. In this manner, these sequences are able to interact with a variety of external targets or ligands [3] . There are three general categories of phage display vectors. Type 3 and 33 are two of the most common phage display vectors that have been developed. There is one copy of the PIII gene in the type 3 vector, and the peptide fragment is cloned in a frame with the PIII gene. The type 33 vector contains two copies of the PIII gene, one wild type and one synthetic. Unlike the synthetic PIII gene, which employs a periplasmic signal sequence in wild type, the signal sequence consists of an endogenous 18 amino acids. In addition, the wild-type PI","cbCaifPMQADTf9rX","https://ap.wps.com/l/cbCaifPMQADTf9rX","pdf",5151758,22,"English","# Introduction\n## Phage display concept and historical basis\n## Phage display vectors and commonly used designs\n## Library generation and identification workflow\n## Applications to antigen/epitope discovery\n## Role of M13 and coat proteins\n## Selection process overview","[{\"question\":\"What is phage display technology used for in biomarker research?\",\"answer\":\"Phage display supports the creation of antibodies that bind specifically to complex antigens, enabling biomarker identification and advancements in diagnostics and treatment strategies.\"},{\"question\":\"How does phage display contribute to identifying peptides and antigens?\",\"answer\":\"It addresses challenges in mapping peptides and antigens across different epitope and peptide spectra by providing a versatile framework for selection and binding discovery.\"},{\"question\":\"Why does this review focus on non-cancerous diseases?\",\"answer\":\"Existing reviews often underrepresent phage display’s importance beyond oncology. The work emphasizes its role across degenerative diseases, inflammatory and autoimmune diseases, and chronic non-communicable diseases.\"}]","Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases - Review | PDF",1790031765,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34d9594d270fb6d21bb6957a64e5004c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/261c88ca598c8aa4c678db2faef948b0.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5fea8133c2a6d3222029327a120a2e7.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30f601efe5ea3e3d3fcb8a26e6592fc2.webp",980,1385]